Scleroderma Skin Complications and Treatments Along with the signature skin fibrosis (hardening) that characterizes scleroderma, there are other scleroderma complications related to the skin that may occur. Raynaud’s Phenomenon Nearly 90% of those with scleroderma have Raynaud’s phenomenon symptoms. Raynaud’s phenomenon affects nearly all people with systemic sclerosis and often appears months to years before other symptoms of scleroderma. Skin Ulcers For people with scleroderma, complications in the form of skin ulcers most often appear at the tips of fingers (digital ulcers), may extend under the nails, or to the joints at pressure points. Calcinosis Calcinosis is a complication of scleroderma where an abnormal collection of calcium salts form under the skin and in muscles or tendons. Telangiectasia Telangiectasias are abnormal blood vessels that usually appear as red dots on the skin or may look like varicose veins, with a spider-web form. Skin Fibrosis More than 90% of people living with systemic scleroderma (SSc) experience skin fibrosis. Severe skin tightening can impair the use of fingers and toes. The skin of the face may also tighten and harden, especially around the mouth. More Resources Resources for Newly Diagnosed There is a lot to understand about this complicated disease. Here is a place to get started. Treatment Centers Patients who are diagnosed with scleroderma are encouraged to receive care at a specialized Treatment Center. Webinar Series Scleroderma Research Foundation collaborates and co-hosts free online webinars providing scleroderma health and wellbeing. SRF Webinars: Skin Complications Scleroderma Skin Care (2026) Get practical skin-care guidance from Dr. Heidi Jacobe and hear firsthand strategies for managing scleroderma skin symptoms. New Directions for Scleroderma Treatments, with Dr. Andrew Tager (2013) Discover how researchers are targeting fibrosis and exploring new treatment directions that could help prevent or reverse scarring in scleroderma. Load More The Latest News & Stories About Complications and Treatments Raise Awareness November 9, 2026 PH Awareness Month: Understanding the Importance of Early Screening November is Pulmonary Hypertension (PH) Awareness Month, which is an opportunity to shine a light on this severe condition and share critical information on how it affects people living with scleroderma. PH is a general term for high blood pressure in the arteries of the lungs. It can have several... Education November 5, 2026 Your Scleroderma Questions, Answered: Understanding Pulmonary Arterial Hypertension (PAH) Your Scleroderma Questions, Answered is a monthly Q&A column featuring responses from the SRF’s Chief Medical Officer, Dr. Gregory Gordon, who shares guidance grounded in decades of clinical expertise. In this edition, he answers questions about the development and treatment of pulmonary arterial hypertension (PAH). Question: Why does scleroderma cause PAH? ... Raise Awareness November 5, 2026 PH Awareness Month: Lorenzo Goes with the Flow "As far as scleroderma and PAH go, I just 'go with the flow,'" says Lorenzo T. (dx 2012), who lives with diffuse scleroderma, interstitial lung disease (ILD), and pulmonary arterial hypertension (PAH). "I will not allow this disease to rule my life." November is Pulmonary Hypertension (PH) Awareness Month. PH... Raise Awareness November 2, 2026 November is PH Awareness Month—Learn Why Early Screening Matters Pulmonary arterial hypertension (PAH) is one type of pulmonary hypertension (PH)—a general term for high blood pressure in the arteries of the lungs. PH can have several causes, and doctors group it into types based on what’s causing it. PAH is the type of PH most closely linked to scleroderma... View All News & Stories